The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies
JBI Evidence Synthesis · 2024-03 · 22 (3) · 378-388
DOI: 10.11124/jbies-23-00268 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JBI Evidence Synthesis, 2024-03. Verfasst von Timothy H Barker und 10 weiteren Autor:innen. Beteiligte Einrichtung: JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Bias, Research Design. Die Arbeit wurde bisher 884-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Systematic reviews of effectiveness offer a rigorous synthesis of the best evidence available regarding the effects of interventions or treatments. Randomized controlled trials are considered the optimal study design for evaluating the effectiveness of interventions and are the ideal study design for inclusion in a systematic review of effectiveness. In the absence of randomized controlled trials, quasi-experimental studies may be relied on to provide information on treatment or intervention effectiveness. However, such studies are subject to unique considerations regarding their internal validity and, consequently, the assessment of the risk of bias of these studies needs to consider these features of design and conduct. The JBI Effectiveness Methodology Group has recently commenced updating the suite of JBI critical appraisal tools for quantitative study designs to align with the latest advancements in risk of bias assessment. This paper presents the revised critical appraisal tool for risk of bias assessment of quasi-experimental studies; offers practical guidance for its use; provides examples for interpreting the results of risk of bias assessment; and discusses major changes from the previous version, along with the justifications for those changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
- Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, The University of Adelaide, Adelaide, SA, Australia.
- The Nottingham Centre for Evidence-Based Healthcare: A JBI Centre of Excellence, School of Medicine, The University of Nottingham, Nottingham, UK.
- Queen's Collaboration for Health Care Quality, Queen's University, Kingston, Ontario, Canada.
- Cochrane Czech Republic, The Czech Republic: A JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
- Center of Evidence-based Education and Arts Therapies: A JBI Affiliated Group, Faculty of Education, Palacký University Olomouc, Czech Republic.
Zitieren
APA
Barker, T. H., Habibi, N., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., Hasanoff, S., Klugar, M., Tufanaru, C., Moola, S., & Munn, Z. (2024). The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evidence Synthesis, 22(3), 378-388. https://doi.org/10.11124/jbies-23-00268
Vancouver
Barker TH, Habibi N, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evidence Synthesis. 2024;22(3):378-388. doi:10.11124/jbies-23-00268
BibTeX
@article{Barker2024,
author = {Barker, Timothy H and Habibi, Nahal and Aromataris, Edoardo and Stone, Jennifer C and Leonardi-Bee, Jo and Sears, Kim and Hasanoff, Sabira and Klugar, Miloslav and Tufanaru, Catalin and Moola, Sandeep and Munn, Zachary},
title = {The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies},
journal = {JBI Evidence Synthesis},
year = {2024},
volume = {22},
number = {3},
pages = {378--388},
doi = {10.11124/jbies-23-00268}
}
EUVIMED